The wireless pacemaker developer secured $50m in an Ascension Ventures-backed round that took its total funding past the $150m mark.

Medidata, Amgen, Merck & Co, Roche, Ascension, Intermountain and General Electric all took part in a round that boosted Syapse's total funding to almost $70m.

Bill Gates has invested $50m in the corporate-backed fund, which is financing treatments and technologies to fight dementia.

Unternehmertum Venture Capital Partners has returned to back a series B round for Dynamic Biosensors, a spinout from Technical University of Munich.

The Pittsburgh spinout is building a precision diagnostic platform that uses genomics to underpin research into conditions such as chronic pancreatic disease.

Neophore was launched by University of Cambridge biopharmaceutical developer PhoreMost in May 2017 to home in on potential immunotherapies for cancer.

Pennsylvania spinout Apellis Pharmaceuticals has floated on the Nasdaq Global Select Market after raising $150m in its initial public offering.

Providence Health & Services and Kaiser Permanente have formed part of care management platform Collective Medical's $47.5m series A round.

Immunotherapy developer Arcus Biosciences, backed by Stanford University, has raised series C funding from a GV-led consortium that included Celgene and Taiho.